Why seven in ten women experience pregnancy sickness

January 29, 2024

A Cambridge-led study has shown why many women experience nausea and vomiting during pregnancy – and why some women, including the then Duchess of Cambridge, become so sick they need to be admitted to hospital. The discovery, published today in Nature, points to a potential way to prevent pregnancy sickness by exposing mothers to GDF15 ahead of pregnancy to build up their resilience. Although some therapies exist to treat pregnancy sickness and are at least partially effective, widespread ignorance of the disorder compounded by fear of using medication in pregnancy mean that many women with this condition are inadequately treated. Until recently, the cause of pregnancy sickness was entirely unknown. When I tried to find out why, I realised how little was known about my condition, despite pregnancy nausea being very common.

A Cambridge-led study has shown why many women experience nausea and vomiting during pregnancy – and why some women, including the then Duchess of Cambridge, become so sick they need to be admitted to hospital.

The culprit is a hormone produced by the fetus – a protein known as GDF15. But how sick the mother feels depends on a combination of how much of the hormone is produced by the fetus and how much exposure the mother had to this hormone before becoming pregnant.

The discovery, published today in Nature, points to a potential way to prevent pregnancy sickness by exposing mothers to GDF15 ahead of pregnancy to build up their resilience.

As many as seven in ten pregnancies are affected by nausea and vomiting. In some women – thought to be between one and three in 100 pregnancies – it can be severe, even threatening the life of the fetus and the mother and requiring intravenous fluid replacement to prevent dangerous levels of dehydration. So-called hyperemesis gravidarum is the commonest cause of admission to hospital of women in the first three months of pregnancy.

Although some therapies exist to treat pregnancy sickness and are at least partially effective, widespread ignorance of the disorder compounded by fear of using medication in pregnancy mean that many women with this condition are inadequately treated.

Until recently, the cause of pregnancy sickness was entirely unknown. Recently, some evidence, from biochemical and genetic studies has suggested that it might relate to the production by the placenta of the hormone GDF15, which acts on the mother’s brain to cause her to feel nauseous and vomit.

Now, an international study, involving scientists at the University of Cambridge and researchers in Scotland, the USA and Sri Lanka, has made a major advance in understanding the role of GDF15 in pregnancy sickness, including hyperemesis gravidarum.

The team studied data from women recruited to a number of studies, including at the Rosie Maternity Hospital, part of Cambridge University Hospitals NHS Foundation Trust and Peterborough City Hospital, North West Anglia NHS Foundation Trust. They used a combination of approaches including human genetics, new ways of measuring hormones in pregnant women’s blood, and studies in cells and mice.

The researchers showed that the degree of nausea and vomiting that a woman experiences in pregnancy is directly related to both the amount of GDF15 made by the fetal part of placenta and sent into her bloodstream, and how sensitive she is to the nauseating effect of this hormone.

GDF15 is made at low levels in all tissues outside of pregnancy. How sensitive the mother is to the hormone during pregnancy is influenced by how much of it she was exposed to prior to pregnancy – women with normally low levels of GDF15 in blood have a higher risk of developing severe nausea and vomiting in pregnancy.

The team found that a rare genetic variant that puts women at a much greater risk of hyperemesis gravidarum was associated with lower levels of the hormone in the blood and tissues outside of pregnancy. Similarly, women with the inherited blood disorder beta thalassemia, which causes them to have naturally very high levels of GDF15 prior to pregnancy, experience little or no nausea or vomiting.

Professor Sir Stephen O’Rahilly, Co-Director of the Institute of Metabolic Science and Director of the Medical Research Council Metabolic Diseases Unit at the University of Cambridge, who led the collaboration, said: “Most women who become pregnant will experience nausea and sickness at some point, and while this is not pleasant, for some women it can be much worse – they’ll become so sick they require treatment and even hospitalisation. We now know why.

"The baby growing in the womb is producing a hormone at levels the mother is not used to. The more sensitive she is to this hormone, the sicker she will become."

Professor Stephen O'Rahilly, University of Cambridge

"Knowing this gives us a clue as to how we might prevent this from happening. It also makes us more confident that preventing GDF15 from accessing its highly specific receptor in the mother’s brain will ultimately form the basis for an effective and safe way of treating this disorder.”

Mice exposed to acute, high levels of GDF15 showed signs of loss of appetite, suggesting that they were experiencing nausea, but mice treated with a long-acting form of GDF15 did not show similar behaviour when exposed to acute levels of the hormone. The researchers believe that building up a woman’s tolerance to the hormone prior to pregnancy could hold the key to preventing sickness.

Co-author Dr Marlena Fejzo from the Department of Population and Public Health Sciences at the University of Southern California whose team had previously identified the genetic association between GDF15 and hyperemesis gravidarum, has first-hand experience with the condition. “When I was pregnant, I became so ill that I could barely move without being sick. When I tried to find out why, I realised how little was known about my condition, despite pregnancy nausea being very common.

“Hopefully, now that we understand the cause of hyperemesis gravidarum, we’re a step closer to developing effective treatments to stop other mothers going through what I and many other women have experienced.”

Dr Marlena Fejzo, University of Southern California

If you have experienced hyperemesis gravidarum and would like to find out how you can help the research team, please fill out the online survey.

The source of this news is from University of Cambridge

Popular in Research

1

3 days ago

Bringing Crises into Focus

2

Jun 14, 2024

Visionary cognitive neuroscientist Susan Courtney dies at 57

3

Jun 7, 2024

From ashes to adversity: Lessons from South Australia's business recovery amidst bushfires and pandemic

4

Jun 14, 2024

Tornados leave trail of destruction as 4 injured, hundreds of homes damaged

5

Jun 14, 2024

SV-faculty becomes partner in two new doctoral networks

Statement by NYU Spokesperson John Beckman about Situation on Greene St. Walkway

3 days ago

NATO chief says Ukraine can still win war despite Russian advances

3 days ago

Trump, Biden and CNN Prepare for a Hostile Debate (With Muted Mics)

3 days ago

The Resistance to a New Trump Administration Has Already Started

3 days ago

Weaving memory into textiles

3 hours ago

How Likely are English Learners to Graduate from High School? New Study Shows It Depends on Race, Gender, and Income

1 day ago